Top

General Thoracic and Cardiovascular Surgery

Published in:

01-04-2013 | Current Topics Review Article

A look at recent improvements in the durability of tissue valves

Authors: Takahiro Nishida, Ryuji Tominaga

Published in: General Thoracic and Cardiovascular Surgery | Issue 4/2013

Abstract

Background

The various uses of biological valves for either aortic or mitral valve replacement have recently increased because of the growing proportion of elderly patients requiring surgery.

Results

The durability of recent xenografts has been reported to be over 90 % at 10 years after aortic or mitral valve replacement for elderly patients more than 65 years of age, and therefore the guidelines now recommend the use of bioprostheses for patients over 65 years of age. Bioprostheses are also recommended for valve replacement of the right side of the heart by several authors; however, no clear guidelines are available. Trans-catheter aortic valve replacement and percutaneous pulmonary valve implantation are promising procedures for high-risk patients, although evaluation of the long-term durability of these valves is mandatory.

Conclusions

This article will review the development of the tissue valve for valve surgery.

Bonow RO, Carabello BA, Chatterjee K, De Leon AC Jr, Faxon DP, Freed MD, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e523–661.PubMedCrossRef

Kuwano H, Amano J, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2010: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2012;60:680–708.PubMedCrossRef

Yasui H, Osada H, Ando N, Koyanagi H. Thoracic and cardiovascular surgery in Japan during 1996: annual report by the Japanese Association for Thoracic Surgery. Committee of science. Jpn J Thorac Cardiovasc Surg. 1998;46:406–20.PubMedCrossRef

Revuelta JM, Alonso C, Cagigas JC, Lequerica MA, Gaite L, Herrera S, et al. Long-term evaluation of the Ionescu-Shiley pericardial xenograft bioprosthesis in the aortic position. J Card Surg. 1988;3:391–6.PubMed

Cohn LH, Collins JJ Jr, DiSesa VJ, Couper GS, Peigh PS, Kowalker W, et al. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann Surg. 1989;210:435–42. (discussion 42–3).PubMedCrossRef

Kirali K, Guler M, Tuncer A, Daglar B, Ipek G, Isik O, et al. Fifteen-year clinical experience with the biocor porcine bioprostheses in the mitral position. Ann Thorac Surg. 2001;71:811–5.PubMedCrossRef

Jamieson WR, Burr LH, Miyagishima RT, Germann E, Macnab JS, Stanford E, et al. Carpentier-Edwards supra-annular aortic porcine bioprosthesis: clinical performance over 20 years. J Thorac Cardiovasc Surg. 2005;130:994–1000.PubMedCrossRef

Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM, David TE. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis. 2006;15:49–55. (discussion-6).PubMed

Rizzoli G, Mirone S, Ius P, Polesel E, Bottio T, Salvador L, et al. Fifteen-year results with the Hancock II valve: a multicenter experience. J Thorac Cardiovasc Surg. 2006;132:602–9. 9 e1-4.PubMedCrossRef

10.

Eichinger WB, Hettich IM, Ruzicka DJ, Holper K, Schricker C, Bleiziffer S, et al. Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position. Ann Thorac Surg. 2008;86:1204–10.PubMedCrossRef

11.

Jamieson WR, Gudas VM, Burr LH, Janusz MT, Fradet GJ, Ling H, et al. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement? Eur J Cardiothorac Surg. 2009;35:104–10.PubMedCrossRef

12.

Myken PS, Bech-Hansen O. A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg. 2009;137:76–81.PubMedCrossRef

13.

Chan V, Kulik A, Tran A, Hendry P, Masters R, Mesana TG, et al. Long-term clinical and hemodynamic performance of the Hancock II versus the Perimount aortic bioprostheses. Circ. 2010;122:S10–6.CrossRef

14.

Riess FC, Cramer E, Hansen L, Schiffelers S, Wahl G, Wallrath J, et al. Clinical results of the Medtronic Mosaic porcine bioprosthesis up to 13 years. Eur J Cardiothorac Surg. 2010;37:145–53.PubMedCrossRef

15.

Jamieson WR, Lewis CT, Sakwa MP, Cooley DA, Kshettry VR, Jones KW, et al. St. Jude Medical Epic porcine bioprosthesis: results of the regulatory evaluation. J Thorac Cardiovasc Surg. 2011;141:1449–54. e2.PubMedCrossRef

16.

Jamieson WR, Riess FC, Raudkivi PJ, Metras J, Busse EF, Goldstein J, et al. Medtronic Mosaic porcine bioprosthesis: assessment of 12-year performance. J Thorac Cardiovasc Surg. 2011;142:302–7. e2.PubMedCrossRef

17.

Celiento M, Ravenni G, Milano AD, Pratali S, Scioti G, Nardi C, et al. Aortic valve replacement with the Medtronic Mosaic bioprosthesis: a 13-year follow-up. Ann Thorac Surg. 2012;93:510–5.PubMedCrossRef

18.

Ruggieri VG, Flecher E, Anselmi A, Lelong B, Corbineau H, Verhoye JP, et al. Long-Term Results of the Carpentier-Edwards Supraannular Aortic Valve Prosthesis. Ann Thorac Surg. 2012;94:1191–7.PubMedCrossRef

19.

Ayegnon KG, Aupart M, Bourguignon T, Mirza A, May MA, Marchand M. A 25-year experience with Carpentier-Edwards Perimount in the mitral position. Asian Cardiovasc Thorac Ann. 2011;19:14–9.PubMed

20.

Dellgren G, David TE, Raanani E, Armstrong S, Ivanov J, Rakowski H. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg. 2002;124:146–54.PubMedCrossRef

21.

Jamieson WR, Germann E, Aupart MR, Neville PH, Marchand MA, Fradet GJ. 15-year comparison of supra-annular porcine and PERIMOUNT aortic bioprostheses. Asian Cardiovasc Thorac Ann. 2006;14:200–5.PubMed

22.

Marchand MA, Aupart MR, Norton R, Goldsmith IR, Pelletier LC, Pellerin M, et al. Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesis. Ann Thorac Surg. 2001;71:S236–9.PubMedCrossRef

23.

Minami K, Zittermann A, Schulte-Eistrup S, Koertke H, Korfer R. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg. 2005;80:1699–705.PubMedCrossRef

24.

Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, et al. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg. 2008;136:688–96.PubMedCrossRef

25.

Wheatley DJ, Fisher J, Reece IJ, Spyt T, Breeze P. Primary tissue failure in pericardial heart valves. J Thorac Cardiovasc Surg. 1987;94:367–74.PubMed

26.

Bortolotti U, Milano A, Mazzucco A, Guerra F, Valente M, Thiene G, et al. The Hancock pericardial xenograft: incidence of early mechanical failures at a medium-term follow-up. Eur J Cardiothorac Surg. 1988;2:458–64.PubMedCrossRef

27.

Bortolotti U, Milano A, Guerra F, Mazzucco A, Mossuto E, Thiene G, et al. Failure of Hancock pericardial xenografts: is prophylactic bioprosthetic replacement justified? Ann Thorac Surg. 1991;51:430–7.PubMedCrossRef

28.

Gabbay S, Bortolotti U, Wasserman F, Tindel N, Factor SM, Frater RW. Long-term follow-up of the Ionescu-Shiley mitral pericardial xenograft. J Thorac Cardiovasc Surg. 1984;88:758–63.PubMed

29.

Ionescu MI, Tandon AP, Chidambaram M, Yakirevich VS, Silverton NP. Durability of the pericardial valve. Eur Heart J. 1984;5 Suppl D:101–6.PubMedCrossRef

30.

Gallo I, Nistal F, Revuelta JM, Garcia-Satue E, Artinano E, Duran CG. Incidence of primary tissue valve failure with the Ionescu-Shiley pericardial valve. Preliminary results. J Thorac Cardiovasc Surg. 1985;90:278–80.PubMed

31.

Jamieson WR, Janusz MT, MacNab J, Henderson C. Hemodynamic comparison of second- and third-generation stented bioprostheses in aortic valve replacement. Ann Thorac Surg. 2001;71:S282–4.PubMedCrossRef

32.

David TE, Pollick C, Bos J. Aortic valve replacement with stentless porcine aortic bioprosthesis. J Thorac Cardiovasc Surg. 1990;99:113–8.PubMed

33.

Elkins RC, Thompson DM, Lane MM, Elkins CC, Peyton MD. Ross operation: 16-year experience. J Thorac Cardiovasc Surg. 2008;136(623–30):e5.

34.

de Kerchove L, Rubay J, Pasquet A, Poncelet A, Ovaert C, Pirotte M, et al. Ross operation in the adult: long-term outcomes after root replacement and inclusion techniques. Ann Thorac Surg. 2009;87:95–102.PubMedCrossRef

35.

David TE, Omran A, Ivanov J, Armstrong S, de Sa MP, Sonnenberg B, et al. Dilation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc Surg. 2000;119:210–20.PubMedCrossRef

36.

Brown JW, Fehrenbacher JW, Ruzmetov M, Shahriari A, Miller J, Turrentine MW. Ross root dilation in adult patients: is preoperative aortic insufficiency associated with increased late autograft reoperation? Ann Thorac Surg. 2011;92:74–81 (discussion).PubMedCrossRef

37.

Ross DN. Homograft replacement of the aortic valve. Lancet. 1962;2:487.PubMedCrossRef

38.

Ali A, Abu-Omar Y, Patel A, Sheikh AY, Ali Z, Saeed A, et al. Propensity analysis of survival after subcoronary or root replacement techniques for homograft aortic valve replacement. J Thorac Cardiovasc Surg. 2009;137:334–41.PubMedCrossRef

39.

Vogt F, Kowert A, Beiras-Fernandez A, Oberhoffer M, Kaczmarek I, Reichart B, et al. Pulmonary homografts for aortic valve replacement: long-term comparison with aortic grafts. Heart Surg Forum. 2011;14:E237–41.PubMedCrossRef

40.

Bortolotti U, Milano A, Thiene G, Guerra F, Mazzucco A, Valente M, et al. Early mechanical failures of the Hancock pericardial xenograft. J Thorac Cardiovasc Surg. 1987;94:200–7.PubMed

41.

Thiene G, Bortolotti U, Valente M, Milano A, Calabrese F, Talenti E, et al. Mode of failure of the Hancock pericardial valve xenograft. Am J Cardiol. 1989;63:129–33.PubMedCrossRef

42.

Gabbay S, Bortolotti U, Wasserman F, Factor S, Strom J, Frater RW. Fatigue-induced failure of the Ionescu-Shiley pericardial xenograft in the mitral position. In vivo and in vitro correlation and a proposed classification. J Thorac Cardiovasc Surg. 1984;87:836–44.PubMed

43.

Goldman B, Scully H, Tong C, Mandell R, Butany J, Azuma J, et al. Clinical results of pericardial xenograft valves: the Ionescu-Shiley and Hancock valves. Can J Cardiol. 1988;4:328–32.PubMed

44.

Wells SM, Sacks MS. Effects of fixation pressure on the biaxial mechanical behavior of porcine bioprosthetic heart valves with long-term cyclic loading. Biomaterials. 2002;23:2389–99.PubMedCrossRef

45.

Vesely I. Analysis of the medtronic intact bioprosthetic valve. Effects of “zero-pressure” fixation. J Thorac Cardiovasc Surg. 1991;101:90–9.PubMed

46.

Cohn LH, Collins JJ Jr, Rizzo RJ, Adams DH, Couper GS, Aranki SF. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg. 1998;66:S30–4.PubMedCrossRef

47.

Said SM, Ashikhmina E, Greason KL, Suri RM, Park SJ, Daly RC, et al. Do pericardial bioprostheses improve outcome of elderly patients undergoing aortic valve replacement? Ann Thorac Surg. 2012;93:1868–74. (discussion 74–5).PubMedCrossRef

48.

David TE, Bos J, Rakowski H. Aortic valve replacement with the Toronto SPV bioprosthesis. J Heart Valve Dis. 1992;1:244–8.PubMed

49.

David TE, Puschmann R, Ivanov J, Bos J, Armstrong S, Feindel CM, et al. Aortic valve replacement with stentless and stented porcine valves: a case-match study. J Thorac Cardiovasc Surg. 1998;116:236–41.PubMedCrossRef

50.

El-Hamamsy I, Clark L, Stevens LM, Sarang Z, Melina G, Takkenberg JJ, et al. Late outcomes following freestyle versus homograft aortic root replacement: results from a prospective randomized trial. J Am Coll Cardiol. 2010;55:368–76.PubMedCrossRef

51.

Ennker JA, Ennker IC, Albert AA, Rosendahl UP, Bauer S, Florath I. The Freestyle stentless bioprosthesis in more than 1000 patients: a single-center experience over 10 years. J Card Surg. 2009;24:41–8.PubMedCrossRef

52.

Oosterlinck W, Meuris B, Herregods MC, Vandeplas A, Daenen W, Flameng W, et al. Long-term results with a stentless porcine aortic valve: the Edwards PRIMA model 2500. J Heart Valve Dis. 2009;18:198–206.PubMed

53.

Auriemma S, D’Onofrio A, Brunelli M, Magagna P, Paccanaro M, Rulfo F, et al. Long-term results of aortic valve replacement with Edwards Prima Plus stentless bioprosthesis: eleven years’ follow up. J Heart Valve Dis. 2006;15:691–5 (discussion 5).PubMed

54.

O’Brien MF, Gardner MA, Garlick B, Jalali H, Gordon JA, Whitehouse SL, et al. CryoLife-O’Brien stentless valve: 10-year results of 402 implants. Ann Thorac Surg. 2005;79:757–66.PubMedCrossRef

55.

Desai ND, McCarthy F, Moser W, Szeto WY, Zeeshan A, Brown D, et al. Durability of porcine bioroots in younger patients with aortic root pathology: a propensity-matched comparison with composite mechanical roots. Ann Thorac Surg. 2011;92:2054–60 (discussion 60-1).PubMedCrossRef

56.

Cohen G, Zagorski B, Christakis GT, Joyner CD, Vincent J, Sever J, et al. Are stentless valves hemodynamically superior to stented valves? Long-term follow-up of a randomized trial comparing Carpentier-Edwards pericardial valve with the Toronto stentless porcine valve. J Thorac Cardiovasc Surg. 2010;139:848–59.PubMedCrossRef

57.

Ali A, Halstead JC, Cafferty F, Sharples L, Rose F, Lee E, et al. Early clinical and hemodynamic outcomes after stented and stentless aortic valve replacement: results from a randomized controlled trial. Ann Thorac Surg. 2007;83:2162–8.PubMedCrossRef

58.

Ali A, Halstead JC, Cafferty F, Sharples L, Rose F, Coulden R, et al. Are stentless valves superior to modern stented valves? A prospective randomized trial. Circulation. 2006;114:I535–40.PubMedCrossRef

59.

Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8.PubMedCrossRef

60.

Vassiliades TA Jr, Block PC, Cohn LH, Adams DH, Borer JS, Feldman T, et al. The clinical development of percutaneous heart valve technology. J Thorac Cardiovasc Surg. 2005;129:970–6.PubMedCrossRef

61.

Vassiliades TA Jr, Block PC, Cohn LH, Adams DH, Borer JS, Feldman T, et al. The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI). Ann Thorac Surg. 2005;79:1812–8.PubMedCrossRef

62.

Walther T, Kasimir MT, Doss M, Schuler G, Simon P, Schachinger V, et al. One-year interim follow-up results of the TRAVERCE trial: the initial feasibility study for trans-apical aortic-valve implantation. Eur J Cardiothorac Surg. 2011;39:532–7.PubMedCrossRef

63.

Chan KM, Rahman-Haley S, Mittal TK, Gavino JA, Dreyfus GD. Truly stentless autologous pericardial aortic valve replacement: an alternative to standard aortic valve replacement. J Thorac Cardiovasc Surg. 2011;141:276–83.PubMedCrossRef

64.

Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y, Matsuyama T, et al. Aortic valve reconstruction using self-developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc Thorac Surg. 2011;12:550–3.PubMedCrossRef

65.

Duran CM, Gometza B, Kumar N, Gallo R, Martin-Duran R. Aortic valve replacement with freehand autologous pericardium. J Thorac Cardiovasc Surg. 1995;110:511–6.PubMedCrossRef

66.

Alsoufi B, Al-Shahid M, Manlhiot C, Al-Amri M, McCrindle BW, Fadel B, et al. Mitral valve replacement with the Quattro stentless pericardial bioprosthesis: mid-term clinical and echocardiographic follow up. J Heart Valve Dis. 2010;19:304–11.PubMed

67.

Mohr FW, Lehmann S, Falk V, Metz S, Walther C, Doll N, et al. Clinical experience with stentless mitral valve replacement. Ann Thorac Surg. 2005;79:772–5.PubMedCrossRef

68.

Kawachi Y, Masuda M, Tominaga R, Tokunaga K. Comparative study between St. Jude Medical and bioprosthetic valves in the right side of the heart. Jpn Circ J. 1991;55:553–62.PubMedCrossRef

69.

Van Nooten GJ, Caes FL, Francois KJ, Taeymans Y, Primo G, Wellens F, et al. The valve choice in tricuspid valve replacement: 25 years of experience. Eur J Cardiothorac Surg. 1995;9:441–6. (discussion 6–7).PubMedCrossRef

70.

Dalrymple-Hay MJ, Leung Y, Ohri SK, Haw MP, Ross JK, Livesey SA, et al. Tricuspid valve replacement: bioprostheses are preferable. J Heart Valve Dis. 1999;8:644–8.PubMed

71.

Hwang HY, Kim KH, Kim KB, Ahn H. Mechanical tricuspid valve replacement is not superior in patients younger than 65 years who need long-term anticoagulation. Ann Thorac Surg. 2012;93:1154–60.PubMedCrossRef

72.

Ratnatunga CP, Edwards MB, Dore CJ, Taylor KM. Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and biological prostheses. Ann Thorac Surg. 1998;66:1940–7.PubMedCrossRef

73.

Chang BC, Lim SH, Yi G, Hong YS, Lee S, Yoo KJ, et al. Long-term clinical results of tricuspid valve replacement. Ann Thorac Surg. 2006;81:1317–23. (discussion 23–4).PubMedCrossRef

74.

Garatti A, Nano G, Bruschi G, Canziani A, Colombo T, Frigiola A, et al. Twenty-five year outcomes of tricuspid valve replacement comparing mechanical and biologic prostheses. Ann Thorac Surg. 2012;93:1146–53.PubMedCrossRef

75.

Kawachi Y, Tominaga R, Hisahara M, Nakashima A, Yasui H, Tokunaga K. Excellent durability of the Hancock porcine bioprosthesis in the tricuspid position. A sixteen-year follow-up study. J Thorac Cardiovasc Surg. 1992;104:1561–6.PubMed

76.

Kuwaki K, Komatsu K, Morishita K, Tsukamoto M, Abe T. Long-term results of porcine bioprostheses in the tricuspid position. Surg Today. 1998;28:599–603.PubMedCrossRef

77.

Nakano K, Ishibashi-Ueda H, Kobayashi J, Sasako Y, Yagihara T. Tricuspid valve replacement with bioprostheses: long-term results and causes of valve dysfunction. Ann Thorac Surg. 2001;71:105–9.PubMedCrossRef

78.

Stulak JM, Dearani JA, Burkhart HM, Connolly HM, Warnes CA, Suri RM, et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg. 2010;90:2009–14. (discussion 14–5).PubMedCrossRef

79.

Balaguer JM, Byrne JG, Cohn LH. Orthotopic pulmonic valve replacement with a pulmonary homograft as an interposition graft. J Card Surg. 1996;11:417–20.PubMedCrossRef

80.

Eyskens B, Reybrouck T, Bogaert J, Dymarkowsky S, Daenen W, Dumoulin M, et al. Homograft insertion for pulmonary regurgitation after repair of tetralogy of fallot improves cardiorespiratory exercise performance. Am J Cardiol. 2000;85:221–5.PubMedCrossRef

81.

Oosterhof T, Meijboom FJ, Vliegen HW, Hazekamp MG, Zwinderman AH, Bouma BJ, et al. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J. 2006;27:1478–84.PubMedCrossRef

82.

Vohra HA, Whistance RN, Baliulis G, Janusauskas V, Kaarne M, Veldtman GR, et al. Midterm evaluation of biological prosthetic valves in the pulmonary position of grown-up patients. Thorac Cardiovasc Surg. 2012;60:205–9.PubMedCrossRef

83.

Shiokawa Y, Sonoda H, Tanoue Y, Nishida T, Nakashima A, Tominaga R. Pulmonary valve replacement long after repair of tetralogy of Fallot. Gen Thorac Cardiovasc Surg. 2012;60:341–4.PubMedCrossRef

84.

Lee C, Park CS, Lee CH, Kwak JG, Kim SJ, Shim WS, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2011;142:351–8.PubMedCrossRef

85.

Miyazaki A, Yamamoto M, Sakaguchi H, Tsukano S, Kagisaki K, Suyama K, et al. Pulmonary valve replacement in adult patients with a severely dilated right ventricle and refractory arrhythmias after repair of tetralogy of fallot. Circ J. 2009;73:2135–42.PubMedCrossRef

86.

George I, Shah JN, Bacchetta M, Stewart A. Stentless bioprosthesis in a valved conduit: implications for pulmonary reconstruction. Ann Thorac Surg. 2009;88:2022–4.PubMedCrossRef

87.

Hawkins JA, Sower CT, Lambert LM, Kouretas PC, Burch PT, Kaza AK, et al. Stentless porcine valves in the right ventricular outflow tract: improved durability? Eur J Cardiothorac Surg. 2009;35:600–4. (discussion 4–5).PubMedCrossRef

88.

Guccione P, Milanesi O, Hijazi ZM, Pongiglione G. Transcatheter pulmonary valve implantation in native pulmonary outflow tract using the Edwards SAPIEN transcatheter heart valve. Eur J Cardiothorac Surg. 2012;41:1192–4.PubMedCrossRef

89.

Eicken A, Ewert P, Hager A, Peters B, Fratz S, Kuehne T, et al. Percutaneous pulmonary valve implantation: two-centre experience with more than 100 patients. Eur Heart J. 2011;32:1260–5.PubMedCrossRef

90.

Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189–97.PubMedCrossRef

91.

Chen PC, Sager MS, Zurakowski D, Pigula FA, Baird CW, Mayer JE Jr, et al. Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2012;143:352–60.PubMedCrossRef

92.

Batlivala SP, Emani S, Mayer JE, McElhinney DB. Pulmonary valve replacement function in adolescents: a comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg. 2012;93:2007–16.PubMedCrossRef

93.

Zubairi R, Malik S, Jaquiss RD, Imamura M, Gossett J, Morrow WR. Risk factors for prosthesis failure in pulmonary valve replacement. Ann Thorac Surg. 2011;91:561–5.PubMedCrossRef

Title: A look at recent improvements in the durability of tissue valves
Authors: Takahiro Nishida
Ryuji Tominaga
Publication date: 01-04-2013
Publisher: Springer Japan
Published in: General Thoracic and Cardiovascular Surgery / Issue 4/2013
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI: https://doi.org/10.1007/s11748-013-0202-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

A look at recent improvements in the durability of tissue valves

Abstract

Background

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2013

Pulmonary inflammatory pseudotumor observed by bronchoscopy and resected using video-assisted thoracic surgery

LeGoo polymer injection into hydatid cyst would eliminate intraoperative spillage of scolices

Recurrent pleural effusion in yellow nail syndrome successfully treated with video-assisted thoracic surgery: comparison of two surgical strategies in two cases

Registry of the Japanese society of lung and heart–lung transplantation: the official Japanese lung transplantation report 2012

Aortic arch replacement for degenerative aneurysms: advances during the last decade

Cadaveric donor lobar lung transplantation for patients on extracorporeal membrane oxygenation as bridge-to-transplant